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Background: The periodic health check-up has been a fundamental part of routine medical practice for decades,
despite a lack of consensus regarding its value in health promotion and disease prevention. A large-scale Danish
population-based preventive programme ‘Check your health’ was developed based on available evidence of screening
and successive accepted treatment, prevention for diseases and health promotion, and is closely aligned with the
current health care system.
The objective of the ‘Check your health’ [CORE] trial is to investigate effectiveness on health outcomes of a preventive
health check offered at a population-level to all individuals aged 30–49 years, and to establish the cost-effectiveness.
Methods/Design: The trial will be conducted as a pragmatic household-cluster randomised controlled trial involving
10,505 individuals. All individuals within a well-defined geographical area in the Central Denmark Region, Denmark (DK)
were randomised to be offered a preventive health check (Intervention group, n = 5250) or to maintain routine
access to healthcare until a delayed intervention (Comparison group, n = 5255). The programme consists of a
health examination which yields an individual risk profile, and according to this participants are assigned to one
of the following interventions: (a) referral to a health promoting consultation in general practice, (b) behavioural
programmes at the local Health Centre, or (c) no need for follow-up.
The primary outcomes at 4 years follow-up are: ten-year-risk of fatal cardiovascular event (Heart-SCORE model),
physical activity level (self-report and cardiorespiratory fitness), quality of life (SF12), sick leave and labour market
attachment. Cost-effectiveness will be evaluated according to life years gained, direct costs and total health costs.
Intention to treat analysis will be performed.
Discussion: Results from the largest Danish health check programme conducted within the current healthcare
system, spanning the sectors which share responsibility for the individual, will provide a scientific basis to be
used in the development of systems to optimise population health in the 21st century.
Trial registration: The trial has registered at ClinicalTrials.gov with an ID: NCT02028195 (7. March 2014).* Correspondence: htm@ph.au.dk
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Non-communicable diseases (NCD) such as diabetes
and cardiovascular diseases (CVD) are leading causes of
reduced life expectancy and quality of life in populations
throughout the world. In both industrialised and devel-
oping countries the development of NCD is closely linked
to prevalent health risk factors for example, low physical
activity, obesity and smoking. Furthermore, poor mental
health is a growing health concern that affects not only
quality of life, but also physical health and work capacity
[1]. The periodic health examination has been a funda-
mental part of medical practice for decades, despite a lack
of consensus regarding its value in health promotion and
disease prevention [2]. Previous efficacy and modeling
studies have indicated that preventive health checks and
screening for diabetes and/or CVD are likely to be cost ef-
fective [3,4], and Cooney et al. showed how high-risk and
population strategies are complementary in the reduction
of risk factors for CVD [5]. However, the evidence for
health checks covering more conditions jointly and gen-
eral health as part of routine health care services is incon-
sistent. The review of Boulware et al. [6] suggests that a
periodic health check improves delivery of preventive ser-
vices and may lessen patient worry. A recent Cochrane re-
view [7] found no reduction in morbidity or mortality due
to general health checks, neither for CVD or cancer. The
review compared a variety of health checks in cancer
units, dental care and local communities. However, most
trials had considerable methodological problems, and took
place 20 to 30 years ago, when the preventive medications
in current use had not yet been introduced [8]. Despite
the ongoing controversy about the effect of periodical
health checks, they are systematically offered on a routine
basis in current health care programmes. In the UK the
National Health Service Health Check programme has re-
cently been introduced for all citizens aged 40 to 74 years
to assess individual risk of heart disease, stroke, kidney
disease and diabetes and to support individual risk reduc-
tion via individually tailored advice [9,10]. Similarly, health
checks in different variations and settings are conducted
in the US/Canada [2,8]. In 1992, a Danish study, the
EBELTOFT health promotion study [11,12], investigated
health checks in general practice in a small area in a
population aged 30 to 49 years (approximately 1,500).
At the 5-year follow up the effect on cardiovascular risk
was reported, and an increase in estimated life expect-
ancy was shown [13]. Wilson and Jungner [14] cau-
tioned that early risk assessment is only of use when
accepted treatments for the disease in question are
available. Since 1992, knowledge of disease prevention
has improved, and a wider range of effective treatment
options have become available. Further, the emphasis
on a broad health definition encompassing not only dis-
ease prevention, but also health promotion in general,so as to ensure physical, mental and social health in
general populations, has now become the responsibility
of health authorities [15].
The objective of the pragmatic household cluster-
randomised controlled trial, Check your health (CORE),
is to investigate the effectiveness on health outcomes of
preventive health checks offered at a population level to
all individuals aged 30 to 49 years in a primary care set-
ting, with shared responsibility between the local muni-
cipality and general practice. Furthermore, the objective
is to investigate the cost-effectiveness of the preventive
health check according to life years gained, direct costs
and total health costs.
Methods
Study design and population
The study is designed as a household cluster-randomised
pragmatic trial to investigate the effects of preventive
health checks offered to all adults aged 30 to 49 years in
the municipality of Randers, DK. Administratively, all
citizens who were between 30 to 49 years old and living
in Randers on January 1, 2012, were identified in the
Danish Civil Registers and randomised into five groups
(n = 26,216) (Figure 1). The five groups are to be invited
to attend the health check in the following five con-
secutive calendar years. The second (n = 5,250) and the
fifth group (n = 5,255) compose the study population
for this trial, as the intervention group and the com-
parison group, respectively. The first group serves as a
pilot group for optimising intervention and recruitment
procedures, whereas the third and fourth groups are
populations to be included in other studies.
The intervention group (I) will be invited for a prevent-
ive health check in 2013 to 2014 with follow up after four
years in 2016 to 2017, which is the maximal follow-up
time within the pragmatic design. At this time the com-
parison group (C) will be invited completely analogously
to the initial invitation of the intervention group. The
single-exclusion criterion for not receiving an invitation is
terminal illness as reported by the general practitioner
(GP). Individuals allocated to the intervention or compari-
son group, who die before invitation, will be excluded.
Randomisation
Randomisation was performed on clusters defined by
households based on addresses obtained from the Danish
Civil Register. Cluster randomisation by household was
chosen to minimise the expected contamination between
participants living together, because motivation to change
behaviour after the health checks would potentially impact
the entire household. The randomisation was further bal-
anced on GP level so as to even out the practice workload
over the scheduled five years of the programme. Of 26,216
individuals living in the municipality of Randers, 913 (3.5%)
Figure 1 Participants in the preventive programme, Check your health, Randers, DK 2013.
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Randers. Consequently, these were allocated to an imaginary
GP in the randomisation procedure. For each of the 17,881
households a random index individual was chosen and then
randomised to receive an invitation to a health check in one
of the scheduled five calendar years. All cohabitants were
randomised to the same group regardless of their GP affili-
ation. Thus, all individuals within the same cluster were
invited to a health check at the same point in time. Ran-
domisation was done by an independent statistician. Re-
cruitment for the CORE trial started in summer 2013.
Setting
In Denmark the local and regional health authorities share
responsibility for disease prevention. The preventive health
checks are conducted in Randers municipality in collabor-
ation between the local Randers Health Centre (RHC) and
the GPs, with the GPs signing the invitation. The health
examinations are undertaken at RHC in a test clinic estab-
lished for the Check your health preventive programme.
The RHC has an open-door policy for all citizens in the
geographical area. The centre offers a variety of health
services, including disease management programmes,
smoking cessation, dental services and pharmacy. In DK,
general practice is the primary entry point into the health
care system, and this tax-funded health care system
ensures free access for all citizens to general practice ser-
vices. Danish GPs operate as independent contractors
within the public health service and are remunerated based
on a combination of fee-for-service (2/3) and capitation
basis (1/3) [16].
Intervention
Comparison group: standard prevention and treatment
strategy followed by lagged intervention
The comparison group is offered standard treatment
with free access to the Danish healthcare system and theopen-hour preventive services at the local RHC until the
end of the study period (2017 to 2018), in which the
intervention will be offered. The health examination of
the intervention will provide data for the outcome mea-
surements in the randomised trial.
Intervention group: health examination and risk-stratified
follow-up intervention
The Check your health programme was designed to pro-
mote awareness of and action on health behaviour and
health condition. The programme includes four compo-
nents: (I) an invitation; (II) a health examination including
clinical measures and questionnaires; (III) an individua-
lised health profile pamphlet; and (IV) an offer of further
intervention depending on the risk-profile. The follow-up
intervention is flexible with different options stratified by
the risk profile of the individual (Figure 2).
Invitation
All individuals will receive a postal invitation including
information about the objectives of the Check your
health preventive programme and the content of the
health examination. A suggested appointment time is
provided. The scheduled time may be accepted, modified
or rejected via phone or Internet. If the appointment is
not accepted within 7 days, a reminder is sent out with a
new appointment time. A second reminder is sent 3 weeks
after the first reminder.
Health examination
Questionnaire
Prior to the health examination participants are asked to
answer a web-based questionnaire, which may be com-
pleted in approximately 20 minutes. The questions con-
cern self-reported health (short form 12 (SF12)) and
mental health (SF12 mcs) [17], physical activity level,



















Figure 2 The four components of the preventive programme, Check your health, Randers, Denmark 2013. GP, general practitioner.
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cluding alcohol risk-behaviour (AUDIT) [19] (Table 1).
Participants are informed about the opportunity for
responding to the questionnaire at the RHC if support is
needed for any reason.
Clinical examination
The health professionals at RHC administer the clinical
examination. Participants may wear everyday clothing for
the examination, which takes approximately 40 minutes.
The following measures will be taken: biochemical (gly-
cated haemoglobin (HbA1c), total-cholesterol, low-density
lipoprotein (LDL)), systolic and diastolic blood pressure
(SBP and DBP), spirometer (lung function test) and Aas-
trands submaximal bike-test (cardiorespiratory fitness)
[20]. All biochemical measures are analysed on location
with the following measurements: DCA Vantage Analyzer,
Siemens Healthcare, Siemens AG, Germany (HbA1c), and
Alere Cholestech LDX System, Alere Denmark (lipids). A
CVD risk score is calculated [21,22]. Details about the
measurements are given in Table 1.
An individualised health profile pamphlet
Immediately after the health examination participants
receive their printed individual health profile pamphlet
with the results of each measurement, the CVD risk
score, and an overall assessment of their health condi-
tion. Furthermore, recommendations for follow up ac-
cording to their health profile are given (Table 1). Data
from the health examination, including the question-
naire responses, are transferred directly into the patient’s
file at their GP's office. GPs are contacted immediately if
SBP is above 200 mmHg, if DBP is above 120 mmHg or
if HbA1c is above 8% (63 mmol/mol).
Follow up according to risk profile
Stratification based on the individual health profile deter-
mines whether the follow-up intervention for the partici-
pant should be either (a) referral to a health-promoting
consultation in general practice, (b) targeted behavioural
programmes at RHC, or (c) no identified need for health-
promoting follow up. The algorithm for the stratification
is outlined in Table 1. If referred to general practice, par-
ticipants will have to make an appointment themselves in
line with standard procedures for general practice in DK.The health-promoting consultation is based on shared
decision-making based on a shared agenda [23]. National
clinical guidelines govern how the patients are to be
treated in general practice. The GP has the opportunity to
refer to chronic disease programmes or behavioural pro-
grammes at RHC targeted at participants in the Check
your health programme. For each consultation the GP is
paid 50 Euros based on a specific and tailored economic
remuneration agreement between the Health Authorities
and the General Practice Association (§2 agreement).
Follow-up consultation in the case of, for example, hyper-
tension is paid according to general agreements. All con-
sultations are monitored by regional data for the use of
general practice services. The behavioural interventions
tailored to the participants are provided in the local health
centre RHC and are: healthy diet (10 meetings of 1½ hours
over months); smoking cessation (one to two individual
counselling sessions in person or by phone or mail); a mo-
tivational interview about physical activity (1½ hours with
follow up by phone or mail); alcohol abuse (1½ hours with
follow up by phone or mail); mental health (1½ hours indi-
vidual counselling and 7 group meetings of 2½ hours). A
number of disease-specific self-management courses are
offered to all citizens with chronic obstructive pulmonary
disease, diabetes, CVD or musculoskeletal conditions.
Health professional training
Before enrolment of patients into the CORE trial, all
GPs and health professionals at RHC received informa-
tion on the trial and how the full programme was to be
delivered, and they were offered formal training accord-
ing to their tasks in the programme. The GPs and their
staff were invited to participate in four after-work meet-
ings of 2 hours each for a total of 8 hours before the in-
vitation of the intervention group. The agenda of the
four meetings were: introduction to the programme, the
concept of shared decision-making, how to promote
physical activity, and establishing consensus on the risk
stratification used for follow up. During the study period
the GPs will receive newsletters (mail and email) and an
invitation to visit a dedicated website with information
on all procedures and news in the study. The total edu-
cation offered to each GP was approximately 10 hours
for the trial, combined with the options of receiving ad-
vice and follow up upon individual request.
Table 1 Measurements in the health examination in the preventive programme, Check your health, including technical information and levels for follow up at
the local Health Centre (RHC) or their general practitioner (GP)
Measurement Technical information Levels for referral
Clinical measures BP (mmHg) - systolic and diastolic Measured in sitting position at left arm, three times. To GP:
Average of three measurements If systolic BP ≥140 or
Device: Omron M6 blood pressure monitor, Omron Healthcare Europe BV Diastolic BP ≥95
Immediate referral: 200/120
Height (cm), weight (kg) Device: Seca 222 mechanical telescopic measuring rod, Seca, Germany
BMI (kg/m2) To RHC:
If BMI ≥28 kg/m2
Waist (cm) Device: Seca 203 measuring band, Seca, Deutschland
Quality assurance: inter/intra validation, yearly
Lung function/spirometry Device: EasyOne Diagnostic Spirometer, NDD Medical Tecnologies, inc. MA, USA To GP:
FVC (L,%), FEV1 (L,%), FEV/1FVC If FEV1 or FVC ≤80% or
Quality assurance: daily calibration, yearly intra/intervariation measurements FEV1/FVC ≤0.70
Physical fitness (ml O2/kg/min) Aastrand 1 point submaximal test (ref 20) To RHC:
For men age 30 to 39 yrs: <35
For men age 40 to 49 yrs: <31
Device: Monark 939 E Pendulum Ergometer, Monark Exercise AB, Sweden For women age 30 to 39 yrs: <28
Quality assurance: daily calibration. Yearly external calibration check. Yearly intra/
intervariation measurements
For women age 40 to 49 years: <26
Patient reported by
questionnaire
Smoking Questionnaire: daily, weekly, less than weekly, quitted, never To RHC:
If current smoker
Alcohol use AUDIT measures risk behaviour. (ref 19) To GP:
For men if audit score ≥8 or
NAU ≥21 per week
For women if audit score ≥8* or
NAU ≥14 per week
Number of alchohol units (NAU) per week is estimated on basis of reported
number per weekday.
*During the first 6 months the
referring score was ≥6.
Mental Health SF-12 mcs 2007. Lincoln, RI: QualityMetric Incorporated, 2007.(ref 17) To GP:
If mental component score <35.76
Self-reported general health Question 1 from SF-12: To GP:
In general, would you say your health is: If answer is “Fair” or “Poor”














Table 1 Measurements in the health examination in the preventive programme, Check your health, including technical information and levels for follow up at
the local Health Centre (RHC) or their general practitioner (GP) (Continued)
Biochemical HbA1c Measured in capillary blood To GP:
Device: DCA Vantage Analyzer, Siemens Healthcare, Siemens AG, Germany If HbA1c ≥6,0%/42 mmol/mol
Immediate referral: HbA1c ≥8,0%/
63 mmol/mol
Quality assurance: monthly control test. Every three months: optical calibration test
according to manufacturer guidelines.
Lipid profile (total cholesterol, HDL, LDL,
triglyceride)
Measured in capillary blood To GP:
Device: Alere Cholestech LDX System, Alere Denmark If total cholesterol > =6 mmol/l or





Risk of CVD within 10 years Measured by SCORE (ref 21), includes information on systolic blood pressure, Total
cholesterol, smoking, gender and age. Denmark is categorized as a low-risk country.
To GP:
If score ≥5%
BP, blood pressure; BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory volume at one second; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein;
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measurement procedures, as well as health promotion and
risk communication before the start of the programme.
The training was partly defined to ensure standardisation
and quality, and partly tailored to fit individual competen-
cies and requests due to different educational backgrounds,
for example, Master of Sports Science, Master of Public
Health, nurse, and physiotherapist. Furthermore, the staff
participated in meetings with the research team to ensure
the correct handling of data (two meetings of 2 hours
each). In the intervention period the staff will receive edu-
cation on evidence and feedback for handling of risk condi-
tions such as CVD, hyperglycaemia and diabetes, sedentary
lifestyle and low fitness, alcohol risk behaviour, poor men-
tal health, obesity and insufficient lung function. The meet-
ings will be provided every second month. The total
education consists of approximately 50 hours.
Collaboration and involvement of stakeholders
A steering committee was established with members
from The Central Denmark Region, health department,
the municipality responsible for the health centre, the
GPs and the research team, with the aim of developing
the programme, ensuring implementation and monitor-
ing the budget.
Outcomes
The outcomes of the CORE trial reflect different aspects
of a broad health concept (cardiovascular risk, physical
activity level and self-reported health) and functional
capacity (affiliation to the labour market). Cardiovascular
risk will be measured as the individual ten-year-risk of a
fatal cardiovascular event as estimated by the European
Heart-SCORE from age, gender, smoking status, SBP
and total cholesterol [21]. Physical activity level will be
measured by (1) self-reported physical activity (days/week
with minimum 30 minutes moderate physical activity) and
(2) cardiorespiratory fitness, measured by Aastrands sub-
maximal bike-test [20]. Health-related quality of life will
be measured by the medical outcome study short form 12
health survey (SF12) [24].
Functional capacity will be measured as affiliation to
the labour market (work participation in the last year)
[25], taking into account whether non-affiliation is
self-selected. Information on working status will be col-
lected from a national register of social transfer pay-
ments (DREAM), which includes information on all
public transfer payments administered by Danish minis-
tries and municipalities for Danish citizens on a weekly
basis since 1991. The type of transfer payment is recorded
for each week in which the individual received a benefit
for at least 1 day. At present the DREAM database in-
cludes 114 different codes for social transfer payments. If
no transfer income is recorded for a specific week, theindividual is considered to be self-supporting or on short-
term sick leave (less than 3 weeks). According to sick leave
a citizen in the workforce in DK (employed as well as un-
employed) is entitled to sickness absence compensation
(at the time of this study after 3 weeks of illness), and in
case the employee receives normal salary during sick
leave, the employer receives municipal reimbursement.
Number of sick days last year was obtained from the
Danish Integrated Database for Labour Market Research
(IDA). In DK each person has a unique civil registration
number, which allows unique linkage across all registers.
It is thus possible to get information on each person ac-
cording to not only sociodemographic data and the above
mentioned social transfer data, but also regarding diagno-
ses obtained from inpatient contacts (ICD10 codes) and
medication use from the Register of Medicinal Product
Statistics. Researchers will be blinded to the civil registra-
tion number, as data are linked at Denmark Statistics.The cost-effectiveness evaluation
The economic benefits of the interventions will be
examined in terms of life-years saved and costs. Cost-
effectiveness and efficiency will be determined by compar-
ing mean direct and total costs (direct and productivity
costs) and expected life years gained (LYG) in the inter-
vention group with the comparison group. Direct costs
are intervention and implementation costs, the costs of
medicine and somatic and psychiatric inpatient and out-
patient hospital services as well as services from practi-
tioners (that is, GPs, specialists, dentists, physiotherapists,
chiropractors, opticians, et cetera). The productivity costs
include morbidity costs (days absent from work, rehabili-
tation, and early retirement) and mortality costs, stratified
by 5-year age groups and gender. Cost data will be ob-
tained from Danish registers and include socioeconomic
factors such as education, income, marital/cohabitation
status, and ethnicity.Data obtainment
Measurements at 4-year follow-up (biochemical, an-
thropometric and questionnaire) will be undertaken by
trained staff unaware of study group allocation, and fol-
lowing standard operating procedures, as in the detailed
description of the health examination. Historic register
data detailing sociodemographic information, prescrip-
tions, contacts to GPs, diagnosis from hospital admissions
and workforce will be obtained via Statistics Denmark. Fur-
thermore, similar data will be obtained for a corresponding
population in a comparable municipality to allow control
for the impact of time trends in relevant health outcomes
and externally imposed changes in preventive services and
other procedures.
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The sample size was determined as the number of
people that could be examined in the municipality per
year. With 10,505 enrolled in the trial, equally distrib-
uted between the two groups, an expected standard
error (SE) of their average difference in days per week
with minimum 30 minutes moderate physical activity
was found to be 0.19 days per week. For SBP the ex-
pected SE is 1.30 mmHg. The SEs take into account an
expected loss to follow up of 30%, as well as clustering
due to individuals being allocated to one of approxi-
mately 40 different participating GP units (based on an
assumed intracluster correlation coefficient (ICC) of
0.01, the design effect due to clustering is nearly four)
[26]. Estimates of the variability between individuals in
physical activity and SBP were obtained from recent
population-based Danish studies [18,27]. For physical ac-
tivity, the analysis will use robust variance estimates to
account for the non-normally distributed outcome, while
the analysis of SBP will be adjusted for age. If the ob-
served ICC exceeds 0.01, study precision will benefit
from making comparisons within GP units, and the
above SEs can therefore be considered conservative. The
power to detect a difference of half a day extra per week
with a minimum of 30 minutes moderate physical activ-
ity exceeds 90% (α = 0.05).
Statistical methods for health outcomes
The effects will be analysed according to the intention-
to-treat principle with allowance for household clusters
and with the following outcomes examined at the time
of follow up (re-examination) for both groups: sick leave
will be measured as a dichotomous variable, and as cat-
egories of number of sick-leave periods over 3 weeks.
This analysis will be adjusted for having received other
government-paid pensions, such as early retirement.
Work participation will be described as a fraction of full-
time employment in the 52 weeks before end of follow
up. Adjustments, for example, for education and mater-
nal leave, will be made.
Statistical method for the health economic evaluation
The cost-effectiveness analysis is based on individual-
level data, and the analyses are based on the intention-
to-treat principle with allowance for clustering as above.
The health economic analyses will compare the LYG
relative to the mean direct and total costs (direct and
productivity costs) between the intervention group and
the control group over a four year period. For different
social groups the clinical effect, LYG, the healthcare util-
isation, and the direct costs and productivity costs per
participant, respectively, will be estimated and com-
pared. Additionally, the annual intervention costs will be
estimated for each of the first 3 years for the purpose ofgiving the municipality and the region an overview of
their expenses. The analyses will be reported with sig-
nificance and confidence intervals based on generalized
linear models or bootstrapping. Cost effectiveness ac-
ceptability curves are plotted for a given threshold.
Legal and ethical aspects
The preventive programme, Check your health, is con-
sidered part of the routine activities running in RHC.
The CORE trial has been presented to The Scientific
Ethics Committee, Central Denmark and according to
law number 593 of 14 June 2011, which relates to the
scientific ethical treatment of health scientific research
in DK; the used data are considered routine data and
thus, ethical approval is not needed when used for the
trial. The study will comply with the Helsinki Declar-
ation. In agreement with the Danish Health Law each
participant prior to their health examination has pro-
vided written informed consent for data to be used for
research purposes., and written informed consent to use
data for research properties will be obtained from all indi-
viduals, according to the Danish Health Law. The Danish
Data Protection Agency has approved the storage of data at
the Department of Public Health at Aarhus University (ref-
erence number 2012-41-0183). The trial protocol has been
registered at ClincalTrials.gov (identifier NCT02028195).
Discussion
The large-scale Danish population-based preventive health-
check programme, Check your health, targeting all citizens
aged 30 to 49 years in a well-defined area, has been devel-
oped. The programme is based on available evidence on
screening and subsequently accepted treatment, prevention
of diseases and health promotion closely aligned with the
current health care system. The pragmatic trial has been
designed to evaluate a complex primary-care intervention,
which contains invitation, examination/questionnaire, indi-
vidualised health profile and follow up. Pragmatic trials [28]
answer questions about effectiveness by determining the ef-
fect on current healthcare, and are in that respect directly
relevant to participants, funders, communities, and health-
care professionals. The availability of a well-defined popula-
tion in a well-defined area is a major strength in this study
as the entire population - not only participants - can be
followed in registers. This allows direct study of the exter-
nal generalizability and offers the possibility of conducting
intention-to-treat analyses on selected outcomes with virtu-
ally no loss to follow up.
Choice of evaluation and effect measures
This study will evaluate the effect of health checks in a
general population in a 4-year follow-up period. The lo-
gistics of the trial would not in any case allow the inter-
vention to be offered simultaneously to the entire target
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intervention) is, therefore, considered to be the strongest
design to evaluate a realistic health-promotion strategy
within a well-defined geographical area - the municipal-
ity. The trial will not solely assess effectiveness of the
intervention with respect to risk factors, but effective-
ness of a broad range of health and social outcomes, and
the trial establishes the associated costs. While prevent-
ive services can be costly in the short-term, they are
intended to lower overall healthcare expenditures over
time by addressing potential health problems sooner ra-
ther than later. A recent European model study showed
that a health check assessing diabetes, hypertension,
lipids and smoking would be cost effective in the six
countries included, Denmark, France, Italy, Germany,
Poland, and the UK [3]. As part of the CORE trial a process
evaluation will be conducted, including awareness of the
ethical and legal issues that might arise from disease- and
risk-screening as part of the health check, as well as from
the health interview. Any screening programme has the po-
tential to label an asymptomatic person as a patient. Being
labelled with a risk factor or a disease could cause anxiety
and have adverse effects. Studies related to screening of in-
dividuals for chronic diseases and conditions have shown
that the level of psychological stress induced by screening is
limited and short lasting [29].
Precision
As the CORE trial involves more than 5,000 participants
in each of the two groups, high precision can be ex-
pected for effect estimates with respect to each of the
outcomes of interest. While the primary outcome of
time spent on exercise is self-reported, and thus may be
prone to recall bias, the use of objectively measured out-
comes and inclusion of register data will allow compari-
sons without this potential misclassification.
Feasibility
As the study strategy is chosen to be pragmatic from the
outset, the study is feasible. Sub-studies will, however,
investigate non-participation, which may threaten overall
generalizability, as well as relevance to certain specific
sub-groups determined by, for example, age, social class
and initial health. Non-participation in preventive health-
care is a well-known challenge [30]. In this study the par-
ticipants are invited by their GP to the health check,
which in former studies has been shown to stimulate a
high level of uptake [31]. However, characterising non-
participants is crucial in evaluating any population-based
intervention. Besides obtaining register data for all non-
participants and participants, this study will explore the
uptake, views and experiences of invited individuals
with qualitative methods and descriptive statistics at
the three levels of the individual, health professionaland organisational and leadership practice. A considerable
diversity in implementation of the UK National Health Ser-
vices Health Check has been reported among general prac-
tices [32]. This study overcomes this by being locally
anchored with a formal quality assurance process in place
in order to optimise the implementation of the programme.
The implementation will take into account the international
literature on the organisation of health services, which
emphasizes that the success of initiatives such as health
checks tend to build on collaboration among a variety of
organisations/professionals, as well as well-functioning
inter-organisational relations [33].
Limitations of study design
As with most community-based interventions this study
is at risk of having its effect diluted by contamination
[34]. At the individual level, contamination may occur
when participants allocated to the comparison group opt
for a health check prior to their designated appointment
or adopt changes in lifestyle induced by their peers in
the intervention group. Household randomisation may
reduce the extent of contamination. However, participat-
ing in social groups and community activities as such
may still lead to contamination. In the study period, GPs
will increase their awareness of health checks. This may
lead to either postponing health checks for some patients
or inviting some patient earlier than designated with an
increase in requests for health checks as the consequence.
Although GPs will be asked not to change their practice, it
would be regarded unethical to deny patients and/or GPs
this option. The magnitude of this possible contamination
effect will be analysed using data on consultations ob-
tained from the National Health Service Register. Further-
more, contamination can also occur by the extra attention
paid by Randers Municipality to physical activity initiatives
and other health promotion activities over the study
period. This will be addressed by using the unique regis-
ters in Denmark to compare the health status in Randers
municipality with similar municipalities matched by age,
gender, and social-demography. Similarly, secular trends
in health attitude and behaviour over the 4-year follow-up
period may affect health status in the control group before
their first health check, which is the measurement used
for comparison with the intervention group. These trends
may dilute or inflate the apparent effect if they are not
mirrored by similar changes in the intervention group.
Differences in health trends between the intervention and
comparison group can, however, to some extent be ex-
plored and controlled for by our use of national routine
register data over the study period.
Interpretation of results
Results from the largest Danish health-check preventive
programme conducted within the current healthcare
Maindal et al. Trials 2014, 15:341 Page 10 of 11
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the individual, will provide a scientific basis that is of
immediate relevance for primary care health services pri-
orities. The anticipated high validity of the CORE trial
will provide evidence about the benefits, uptake, harm
and costs of preventive health checks studied over a 4-
year period. Further the trial design allows study of
whether preventive health checks provide sustained ef-
fects on disease patterns and mortality. Such evidence is
required when attempting to develop health care sys-
tems that may optimise population health in the 21st
century.
Trial status
The trial at the time of submission of this manuscript
has enrolled approximately 2,000 participants. Recruit-
ment is ongoing.
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